Status:
COMPLETED
Investigating the Association of Shock Index and Hemoglobin Variation With Postpartum Hemorrhage After Vaginal Deliveries
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
16-50 years
Brief Summary
Postpartum hemorrhage (PPH) is a leading cause of maternal mortality and morbidity, and is most commonly caused by poor uterine tone after delivery of the baby and placenta. Currently, a lack of early...
Detailed Description
The investigators believe that trends in patient-specific SI combined with continuous SpHb monitoring, will be useful to identify PPH and the immediate need for pharmacotherapy, as well as the need fo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients who give written consent to participate in this study
- all term laboring patients including spontaneous and induced labor (gestational age \>37 weeks) undergoing spontaneous vaginal delivery or instrumental delivery
- Exclusion criteria
- patients who refuse to give written informed consent
- patients with cardiac rhythm abnormalities or cardiac diseases
- patients undergoing elective/emergency CD
- patients with jaundice
- patients with abnormal Hb--\>Such as Sickle cell disease and Thalassemia
- patients with peripheral vascular disease
- patients with hypertension and preeclampsia
- patients on medications affecting blood pressure such as anti hypertensives (including Magnesium Sulphate), and those affecting HR (including beta blockers)
Exclusion
Key Trial Info
Start Date :
February 16 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 11 2019
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT03432767
Start Date
February 16 2016
End Date
January 11 2019
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G1X5